Page last updated: 2024-09-20

uridine diphosphate

Description

UDP(3-) : A nucleoside 5'-diphosphate(3-) arising from deprotonation of the diphosphate OH groups of uridine 5'-diphosphate (UDP); major species at pH 7.3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Uridine Diphosphate: A uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID20056717
CHEMBL ID1096401
CHEBI ID58223
MeSH IDM0022345
PubMed CID6031
CHEMBL ID130266
CHEBI ID17659
SCHEMBL ID4245
MeSH IDM0022345

Synonyms (70)

Synonym
uridine 5'-diphosphate trianion
uridine 5'-diphosphate(3-)
udp(3-)
udp trianion
5'-o-[(phosphonatooxy)phosphinato]uridine
CHEBI:58223
uridine-diphosphate
2VL8
CHEMBL1096401 ,
uridine diphosphate trisodium salt
bdbm50318022
[[(2r,3s,4r,5r)-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanidyl-phosphoryl] phosphate
A832095
[[(2r,3s,4r,5r)-5-(2,4-dioxo-1-pyrimidinyl)-3,4-dihydroxy-2-oxolanyl]methoxy-oxidophosphoryl] phosphate
2WZF
3DXH
4DMW
4AY5
3DJQ
Q27125623
86527-70-0
uridine 5'-(trihydrogen diphosphate), ion(3-)
DTXSID301253877
[[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate
uridine pyrophosphate
gtpl1749
uridine 5'-(trihydrogen diphosphate)
uridine diphosphate
CHEBI:17659 ,
LOPAC0_001205
2,4(1h,3h)-pyrimidinedione, 1-[5-o-[hydroxy(phosphonooxy)phosphinyl]-beta-d-ribofuranosyl]-
uridine 5'-(trihydrogen diphosphate-p-32p) (9ci)
uridine 5'-pyrophosphate
uridine 5'-pyrophosphoric acid
uridine, 5'-(trihydrogen diphosphate)
uridine diphosphate (6ci)
uridine 5'-(trihydrogen pyrophosphate) (8ci)
uridine 5'-(trihydrogen diphosphate) (9ci)
5'-udp
uridine 5'-(trihydrogen pyrophosphate)
uridine pyrophosphate (7ci)
uridine 5'-diphosphate
58-98-0
UDP ,
uridine-5'-diphosphate
C00015
DB03435
1O7O
1GWW
1GX4
NCGC00163324-01
einecs 200-409-6
CHEMBL130266 ,
bdbm50118239
uridine 5''-(trihydrogen diphosphate)
BMSE000266
[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate
bdbm50403871
uridine_diphosphate
5g0f599a1y ,
unii-5g0f599a1y
uridine 5'-diphosphate [mi]
uridine 5'-diphosphoric acid
SCHEMBL4245
XCCTYIAWTASOJW-XVFCMESISA-N
[({[(2r,3s,4r,5r)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid
uridine 5'-pyrophosphorate
Q412593
DTXSID001018933
((2r,3s,4r,5r)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyltrihydrogendiphosphate

Research Excerpts

Overview

ExcerptReference
"Uridine diphosphate (UDP) is a proinflammatory nucleotide implicated in inflammatory bowel disease. "( Alam, SN; Hamarneh, SR; Hodin, RA; Hohmann, E; Kaliannan, K; Malo, MS; Malo, NS; Millán, JL; Moaven, O; Mohamed, MM; Moss, AK; Muhammad, N; Narisawa, S; Patel, P; Ramasamy, S; Teshager, A; Warren, HS; Yammine, H, 2013)

Roles (4)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
nucleoside 5'-diphosphate(3-)Trianion of nucleoside diphosphate arising from deprotonation of all three free OH groups of the diphosphate; major species at pH 7.3.
uridine 5'-phosphate
pyrimidine ribonucleoside 5'-diphosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (517)

uridine diphosphate is involved in 517 pathway(s), involving a total of 15576 unique proteins and 17120 unique compounds

PathwayProteinsCompounds
Extracellular matrix organization13520
Collagen formation1914
Collagen biosynthesis and modifying enzymes89
Metabolism14961108
Carbohydrate metabolism173120
Glycogen metabolism2016
Glycogen synthesis1010
Lactose synthesis35
Glycosaminoglycan metabolism3637
Keratan sulfate/keratin metabolism918
Keratan sulfate biosynthesis89
Heparan sulfate/heparin (HS-GAG) metabolism1820
A tetrasaccharide linker sequence is required for GAG synthesis55
HS-GAG biosynthesis68
Chondroitin sulfate/dermatan sulfate metabolism1215
Chondroitin sulfate biosynthesis25
Metabolism of lipids500463
Sphingolipid metabolism5550
Glycosphingolipid metabolism3031
Porphyrin metabolism2344
Heme degradation1021
Biological oxidations150276
Phase II - Conjugation of compounds73122
Glucuronidation718
Abacavir ADME624
Abacavir metabolism423
Programmed Cell Death17012
Regulated Necrosis389
RIPK1-mediated regulated necrosis237
Regulation of necroptotic cell death216
Signaling Pathways1269117
Signaling by Receptor Tyrosine Kinases29335
Signaling by FGFR477
Signaling by FGFR3217
FGFR3 ligand binding and activation44
FGFR3c ligand binding and activation34
Signaling by GPCR24955
GPCR ligand binding19339
Class A/1 (Rhodopsin-like receptors)16136
Nucleotide-like (purinergic) receptors127
P2Y receptors126
GPCR downstream signalling17252
G alpha (q) signalling events7928
Signaling by NOTCH11314
Pre-NOTCH Expression and Processing2413
Pre-NOTCH Processing in the Endoplasmic Reticulum24
Pre-NOTCH Processing in Golgi95
Blood group systems biosynthesis913
ABO blood group biosynthesis36
Lewis blood group biosynthesis512
Pyrimidine Metabolism2353
Amino Sugar Metabolism1731
Galactose Metabolism1234
Androgen and Estrogen Metabolism1230
Lactose Synthesis1015
Sphingolipid Metabolism2335
Porphyrin Metabolism1636
17-beta Hydroxysteroid Dehydrogenase III Deficiency1230
Sialuria or French Type Sialuria1731
Salla Disease/Infantile Sialic Acid Storage Disease1731
Ibuprofen Action Pathway5076
Celecoxib Action Pathway3573
Starch and Sucrose Metabolism1626
Acute Intermittent Porphyria1636
Porphyria Variegata (PV)1636
Congenital Erythropoietic Porphyria (CEP) or Gunther Disease1636
beta-Ureidopropionase Deficiency2353
UMP Synthase Deficiency (Orotic Aciduria)2353
Dihydropyrimidinase Deficiency2353
MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)2353
Galactosemia1234
Gaucher Disease2335
Globoid Cell Leukodystrophy2335
Metachromatic Leukodystrophy (MLD)2335
Hereditary Coproporphyria (HCP)1636
Tay-Sachs Disease1731
Irinotecan Action Pathway2411
Etoposide Action Pathway2014
Tamoxifen Action Pathway1027
Phenytoin (Antiarrhythmic) Action Pathway6923
Codeine Action Pathway3420
Morphine Action Pathway4716
Nicotine Action Pathway3832
Fabry Disease2335
Krabbe Disease2335
G(M2)-Gangliosidosis: Variant B, Tay-Sachs Disease1731
Glycogen Synthetase Deficiency1626
Glycogenosis, Type III. Cori Disease, Debrancher Glycogenosis1626
Glycogenosis, Type IV. Amylopectinosis, Anderson Disease1626
Glycogenosis, Type VI. Hers Disease1626
Mucopolysaccharidosis VII. Sly Syndrome1626
Sucrase-Isomaltase Deficiency1626
Aromatase Deficiency1230
Congenital Disorder of Glycosylation CDG-IId1015
GLUT-1 Deficiency Syndrome1015
Ibuprofen Metabolism Pathway2414
Irinotecan Metabolism Pathway2411
Etoposide Metabolism Pathway2014
Tamoxifen Metabolism Pathway1027
Codeine Metabolism Pathway411
Morphine Metabolism Pathway176
Nicotine Metabolism Pathway923
Valproic Acid Metabolism Pathway1132
Tramadol Metabolism Pathway717
Acetaminophen Metabolism Pathway3016
Nevirapine Metabolism Pathway821
Celecoxib Metabolism Pathway811
Sorafenib Metabolism Pathway1612
Lamivudine Metabolism Pathway1816
Artemether Metabolism Pathway410
Mycophenolic Acid Metabolism Pathway1618
Lipopolysaccharide Biosynthesis4153
Amino Sugar and Nucleotide Sugar Metabolism III2340
Peptidoglycan Biosynthesis I3036
Secondary Metabolites: Enterobacterial Common Antigen Biosynthesis917
Metabolism of proteins1058144
Lipopolysaccharide Biosynthesis II4053
Secondary Metabolites: Enterobacterial Common Antigen Biosynthesis 2917
Secondary Metabolites: Enterobacterial Common Antigen Biosynthesis 3820
Polymyxin Resistance418
Lipopolysaccharide Biosynthesis III3352
Peptidoglycan Biosynthesis II3037
Trehalose Biosynthesis I28
Leloir Pathway612
Amino Sugar and Nucleotide Sugar Metabolism2229
N-Glycan Biosynthesis1525
Post-translational protein modification666112
Post-translational modification: synthesis of GPI-anchored proteins2810
Synthesis of glycosylphosphatidylinositol (GPI)188
Asparagine N-linked glycosylation16478
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein5068
Synthesis of substrates in N-glycan biosythesis3756
Synthesis of dolichyl-phosphate-glucose27
Sialic acid metabolism1318
Transport to the Golgi and subsequent modification8518
N-glycan trimming and elongation in the cis-Golgi24
N-glycan antennae elongation in the medial/trans-Golgi2013
Reactions specific to the complex N-glycan synthesis pathway1010
O-linked glycosylation1919
O-glycosylation of TSR domain-containing proteins22
O-linked glycosylation of mucins78
Flavone and Flavonol Biosynthesis627
Anthocyanidin Sambubioside Biosynthesis211
Abscisic Acid Glucose Ester Metabolism717
cis-Zeatin-O-Glucoside Biosynthesis313
Galactolipid Biosynthesis32
cis-Zeatin-N-Glucoside Biosynthesis314
Phenolic Malonylglucosides Biosynthesis213
Disease1278231
Androstenedione Metabolism1823
Estrone Metabolism1622
Infectious disease89579
Ascorbate Biosynthesis414
pyrimidine deoxyribonucleotides de novo biosynthesis III621
orientin and isoorientin biosynthesis I09
betacyanin biosynthesis117
superpathway of anthocyanin biosynthesis (from delphinidin 3-O-glucoside)117
salicylate glucosides biosynthesis II19
u03B1-solanine/u03B1-chaconine biosynthesis38
saponin biosynthesis III07
DIBOA-glucoside biosynthesis713
crocetin esters biosynthesis19
monolignol glucosides biosynthesis111
stachyose biosynthesis523
des-methyl avenacin A-1 biosynthesis34
calycosin 7-O-glucoside biosynthesis15
luteolin triglucuronide biosynthesis09
superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis1034
3,4-dihydroxymandelonitrile u03B2-D-glucose biosynthesis04
anthocyanidin sophoroside metabolism06
daphnin interconversion010
flavonoid di-C-glucosylation022
kaempferol diglycoside biosynthesis (pollen-specific)18
superpathway of hydrolyzable tannin biosynthesis023
salidroside biosynthesis215
superpathway of pyrimidine ribonucleotides de novo biosynthesis622
scopolin biosynthesis15
quercetin gentiotetraside biosynthesis317
salicylate glucosides biosynthesis III23
quercetin glycoside biosynthesis (Arabidopsis)108
B series fagopyritols biosynthesis28
lipid IVA biosynthesis114
gossypetin metabolism025
quercetin triglucoside biosynthesis07
luteolinidin 5-O-glucoside biosynthesis416
indole-3-acetate inactivation III09
protein N-glycosylation initial phase (eukaryotic)418
soybean saponin I biosynthesis316
anthocyanidin acylglucoside and acylsambubioside biosynthesis320
podophyllotoxin glucosides metabolism014
salicin biosynthesis012
naringenin glycoside biosynthesis08
UDP-glucose biosynthesis (from sucrose)05
ternatin C5 biosynthesis09
sulfoquinovosyl diacylglycerol biosynthesis07
anthocyanin biosynthesis110
acylated cyanidin galactoside biosynthesis112
vitexin and derivatives biosynthesis015
medicarpin conjugates interconversion015
6'-deoxychalcone metabolism014
rose anthocyanin biosynthesis II (via cyanidin 3-O-u03B2-D-glucoside)36
hesperitin glycoside biosynthesis010
baicalein metabolism313
furaneol and mesifurane biosynthesis214
sesaminol glucoside biosynthesis58
rutin biosynthesis013
xylan biosynthesis25
UDP-D-apiose biosynthesis (from UDP-D-glucuronate)110
steviol glucoside biosynthesis (rebaudioside A biosynthesis)34
N-methylanthraniloyl-u03B2-D-glucopyranose biosynthesis37
2,4,6-trinitrotoluene degradation39
xylogalacturonan biosynthesis03
sinapate ester biosynthesis221
eupatolitin 3-O-glucoside biosynthesis030
lychnose and isolychnose biosynthesis09
flavonol acylglucoside biosynthesis I - kaempferol derivatives09
trichloroethene degradation014
superpathway of avenacin A biosynthesis615
kaempferol gentiobioside biosynthesis317
maysin biosynthesis06
violdelphin biosynthesis513
anthocyanidin sambubioside biosynthesis115
quercetin glucoside biosynthesis (Allium)29
1,3-u03B2-D-glucan biosynthesis33
phenylethanol glycoconjugate biosynthesis06
saponin biosynthesis IV06
polymethylated quercetin glucoside biosynthesis I - quercetin series (Chrysosplenium)226
cytokinins 7-N-glucoside biosynthesis014
ajmaline and sarpagine biosynthesis137
superpathway of anthocyanin biosynthesis (from pelargonidin 3-O-glucoside)231
pyrimidine ribonucleotides interconversion416
galactolipid biosynthesis I14
genistein conjugates interconversion016
salvianin biosynthesis121
apigenin glycosides biosynthesis011
pinocembrin C-glucosylation37
wogonin metabolism38
daphnetin modification111
superpathway of indole-3-acetate conjugate biosynthesis828
superpathway of pyrimidine ribonucleosides salvage720
benzoyl-u03B2-D-glucopyranose biosynthesis34
cytokinins 9-N-glucoside biosynthesis015
indole-3-acetate inactivation IX017
saponin biosynthesis II013
shisonin biosynthesis117
pelargonidin conjugates biosynthesis223
daidzein conjugates interconversion016
isovitexin glycosides biosynthesis010
geranyl u03B2-primeveroside biosynthesis25
crocetin biosynthesis013
superpathway of benzoxazinoid glucosides biosynthesis920
coniferin metabolism38
coumarin biosynthesis (via 2-coumarate)118
apigeninidin 5-O-glucoside biosynthesis316
chalcone 2'-O-glucoside biosynthesis04
brassinosteroids inactivation210
abscisic acid degradation by glucosylation87
rose anthocyanin biosynthesis I (via cyanidin 5-O-u03B2-D-glucoside)05
superpathway of betalain biosynthesis241
naringenin C-glucosylation29
anthocyanin biosynthesis (pelargonidin 3-O-glucoside)211
indican biosynthesis010
flavonol glucosylation I118
sucrose biosynthesis II1518
cichoriin interconversion013
cellulose biosynthesis12
UTP and CTP de novo biosynthesis311
phenolic malonylglucosides biosynthesis210
luteolin glycosides biosynthesis07
anthocyanidin modification (Arabidopsis)816
myricetin gentiobioside biosynthesis316
biochanin A conjugates interconversion016
ginsenosides biosynthesis225
superpathway of pyrimidine nucleobases salvage514
genistin gentiobioside biosynthesis15
galloylated catechin biosynthesis013
xyloglucan biosynthesis58
sphingolipid biosynthesis (plants)1223
sucrose biosynthesis I (from photosynthesis)1124
anthocyanin biosynthesis (delphinidin 3-O-glucoside)011
homogalacturonan biosynthesis015
stellariose and mediose biosynthesis08
polymethylated quercetin glucoside biosynthesis II - quercetagetin series (Chrysosplenium)231
cardenolide glucosides biosynthesis05
phloridzin biosynthesis212
superpathway of flavones and derivatives biosynthesis1744
kaempferide triglycoside biosynthesis115
esculetin modification219
superpathway of formononetin derivative biosynthesis031
pentagalloylglucose biosynthesis012
superpathway of scopolin and esculin biosynthesis127
N-glucosylnicotinate metabolism06
cinnamate esters biosynthesis14
pyrimidine deoxyribonucleotides de novo biosynthesis I520
flavonol acylglucoside biosynthesis III - quercetin derivatives08
proanthocyanidins biosynthesis from flavanols016
tetrahydrofolate biosynthesis II1232
avenacin A-1 biosynthesis310
secologanin and strictosidine biosynthesis332
hispidol and hispidol 4'-O-u03B2-D-glucoside biosynthesis08
maackiain conjugates interconversion015
flavonol acylglucoside biosynthesis II - isorhamnetin derivatives07
kaempferol glycoside biosynthesis (Arabidopsis)39
curcumin glucoside biosynthesis17
formononetin conjugates interconversion014
eriodictyol C-glucosylation29
aurone biosynthesis019
gentiodelphin biosynthesis113
superpathway of anthocyanin biosynthesis (from cyanidin and cyanidin 3-O-glucoside)519
amaranthin biosynthesis09
kaempferol triglucoside biosynthesis010
afrormosin conjugates interconversion07
superpathway of polymethylated quercetin/quercetagetin glucoside biosynthesis (Chrysosplenium)234
A series fagopyritols biosynthesis18
superpathway of anaerobic sucrose degradation3360
(+)-secoisolariciresinol diglucoside biosynthesis16
tuberonate glucoside biosynthesis09
salicylate glucosides biosynthesis IV35
cytokinin-O-glucosides biosynthesis614
sucrose degradation II (sucrose synthase)1722
quercetin diglycoside biosynthesis (pollen-specific)18
tropane alkaloids biosynthesis028
superpathway of hyoscyamine (atropine) and scopolamine biosynthesis039
Aminosugars metabolism ( Aminosugars metabolism )1529
Galactose metabolism ( Galactose metabolism )913
Pyrimidine Nucleotides and Nucleosides metabolism ( Pyrimidine Nucleotides and Nucleosides metabolism )4549
ATP + UMP = ADP + UDP ( Pyrimidine Nucleotides and Nucleosides metabolism )14
UTP + AMP = UDP + ADP ( Pyrimidine Nucleotides and Nucleosides metabolism )14
ATP + UDP = ADP + UTP ( Pyrimidine Nucleotides and Nucleosides metabolism )74
Biomarkers for pyrimidine metabolism disorders1432
Proteoglycan biosynthesis011
Chitin Biosynthesis921
taxiphyllin biosynthesis214
prunasin and amygdalin biosynthesis015
lotaustralin biosynthesis114
jasmonoyl-L-isoleucine inactivation612
glucosinolate biosynthesis from dihomomethionine627
salicylate glucosides biosynthesis I25
glucosinolate biosynthesis from tryptophan1229
glucosinolate biosynthesis from pentahomomethionine418
glucosinolate biosynthesis from phenylalanine627
glucosinolate biosynthesis from homomethionine629
superpathway of linamarin and lotaustralin biosynthesis123
gentisate 5-O-u03B2-D-xylopyranoside biosynthesis15
dhurrin biosynthesis214
phenylpropanoid volatiles glycoconjugation (tomato)17
glucosinolate biosynthesis from trihomomethionine422
superpathway of methylsalicylate metabolism311
u03B1-tomatine biosynthesis417
glucosinolate biosynthesis from hexahomomethionine419
solasodine glycosylation312
linamarin biosynthesis115
heme degradation I014
glucosinolate biosynthesis from tetrahomomethionine418
glucosinolate biosynthesis from tyrosine021
Renz2020 - GEM of Human alveolar macrophage with SARS-CoV-20490
The impact of Nsp14 on metabolism (COVID-19 Disease Map)084
SARS-CoV Infections28229
SARS-CoV-1 Infection11422
Translation of Structural Proteins1114
Maturation of spike protein37
Maturation of protein 3a25
Pyrimidine synthesis and deprivation pathway (COVID-19 Disease Maps)1329
Purinergic signaling053
SARS-CoV-1 Infection6019
SARS-CoV-2 Infection7720
SARS-CoV-2 Infection19527
Drug ADME6387
Aspirin ADME822
APAP ADME1730
Late SARS-CoV-2 Infection Events3418
Atorvastatin ADME49
Genetic causes of porto-sinusoidal vascular disease09
Prednisone ADME710
superpathway of glycoalkaloid metabolism (Solanaceae)415
complex N-linked glycan biosynthesis (plants)09
leucine-derived hydroxynitrile glucoside biosynthesis09
Viral Infection Pathways72739
11p11.2 copy number variation syndrome216
5q35 copy number variation012
Glycosphingolipid biosynthesis1316
Mycobacterium tuberculosis biological processes3962
Mycothiol metabolism828
Mycothiol biosynthesis619
Trehalose biosynthesis510
super pathway of glycosphingolipids biosynthesis2616
biosynthesis of ABH and Lewis epitopes from type 1 precursor disaccharide68
dolichyl-diphosphooligosaccharide biosynthesis2223
superpathway of tryptophan utilization4292
pyrimidine deoxyribonucleotides de novo biosynthesis1518
biosynthesis of ABH and Lewis epitopes from type 2 precursor disaccharide1310
secologanin and strictosidine biosynthesis1336
i antigen and I antigen biosynthesis65
polymethylated quercetin glucoside biosynthesis I - quercetin series (Chrysosplenium)231
myricetin gentiobioside biosynthesis317
ABH and Lewis epitopes biosynthesis from type 2 precursor disaccharide1410
kaempferol diglycoside biosynthesis (pollen-specific)110
flavonol acylglucoside biosynthesis II - isorhamnetin derivatives013
protein O-[N-acetyl]-glucosylation26
polymethylated quercetin glucoside biosynthesis II - quercetagetin series (Chrysosplenium)238
kaempferol glycoside biosynthesis (Arabidopsis)316
u03B1-dystroglycan glycosylation710
quercetin diglycoside biosynthesis (pollen-specific)110
quercetin glucoside biosynthesis (Allium)211
mucin core 1 and core 2 O-glycosylation77
sarcinaxanthin diglucoside biosynthesis412
decaprenoxanthin diglucoside biosynthesis412
C.p.450 monoglucoside biosynthesis314
CMP-legionaminate biosynthesis II312
chitin biosynthesis1640
ABH and Lewis epitopes biosynthesis from type 1 precursor disaccharide68
homogalacturonan biosynthesis014
acetan biosynthesis622
xyloglucan biosynthesis68
xylogalacturonan biosynthesis14
cellulose biosynthesis62
thyroid hormone metabolism II (via conjugation and/or degradation)632
terminal O-glycans residues modification (via type 2 precursor disaccharide)97
xanthan biosynthesis821
protein O-mannosylation II (mammals, core M1 and core M2)78
UDP-N-acetylmuramoyl-pentapeptide biosynthesis I (meso-diaminopimelate containing)1738
procollagen hydroxylation and glycosylation914
teichuronic acid biosynthesis (B. subtilis 168)1117
sesaminol glucoside biosynthesis512
(+)-secoisolariciresinol diglucoside biosynthesis17
superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis2257
podophyllotoxin glucosides metabolism017
peptidoglycan biosynthesis V (u03B2-lactam resistance)138
mAGP1831
peptidoglycan biosynthesis IV (Enterococcus faecium)336
polymyxin resistance420
enterobacterial common antigen biosynthesis1133
anhydromuropeptides recycling II819
CMP-N-acetylneuraminate biosynthesis I (eukaryotes)738
CMP-N-acetylneuraminate biosynthesis II (bacteria)521
poly(3-O-u03B2-D-glucopyranosyl-N-acetylgalactosamine 1-phosphate) wall teichoic acid biosynthesis1233
sucrose biosynthesis II918
sucrose biosynthesis III115
esculetin modification221
daphnetin modification115
coumarin biosynthesis (via 2-coumarate)018
superpathway of scopolin and esculin biosynthesis131
stellariose and mediose biosynthesis010
sulfoquinovosyl diacylglycerol biosynthesis58
pyrimidine deoxyribonucleotides de novo biosynthesis I3034
protein N-glycosylation initial phase (eukaryotic)2630
Lipid A-core biosynthesis (E. coli K-12)1025
sophorolipid biosynthesis27
salicylate glucosides biosynthesis II110
biochanin A conjugates interconversion017
salicylate glucosides biosynthesis III24
maackiain conjugates interconversion017
daidzein conjugates interconversion017
stachyose biosynthesis323
formononetin conjugates interconversion016
geranyl u03B2-primeveroside biosynthesis27
salicylate glucosides biosynthesis IV25
genistein conjugates interconversion017
medicarpin conjugates interconversion017
pyrimidine deoxyribonucleotides de novo biosynthesis III1130
superpathway of benzoxazinoid glucosides biosynthesis1020
indican biosynthesis011
naringenin C-glucosylation313
hesperitin glycoside biosynthesis011
N-methylanthraniloyl-u03B2-D-glucopyranose biosynthesis38
rhabduscin biosynthesis313
furaneol and mesifurane biosynthesis318
superpathway of melatonin degradation526
melatonin degradation I414
mannosylglucosylglycerate biosynthesis I311
coniferin metabolism29
phenylethanol glycoconjugate biosynthesis07
DIBOA-glucoside biosynthesis813
2,4,6-trinitrotoluene degradation217
heme degradation I314
D-galactose detoxification523
abscisic acid degradation by glucosylation97
UTP and CTP de novo biosynthesis1321
brassinosteroids inactivation215
serotonin degradation721
u03B1-solanine/u03B1-chaconine biosynthesis312
3,4-dihydroxymandelonitrile u03B2-D-glucose biosynthesis05
linamarin biosynthesis015
prunasin and amygdalin biosynthesis115
lotaustralin biosynthesis014
dhurrin biosynthesis114
taxiphyllin biosynthesis014
UDP-sugars interconversion1234
oleandomycin activation/inactivation410
peptidoglycan biosynthesis III (mycobacteria)1236
peptidoglycan biosynthesis I (meso-diaminopimelate containing)1142
nicotine degradation IV428
peptidoglycan biosynthesis II (staphylococci)2044
paromamine biosynthesis I1020
steviol glucoside biosynthesis (rebaudioside A biosynthesis)311
paromamine biosynthesis II522
superpathway of pyrimidine ribonucleosides salvage2237
pinocembrin C-glucosylation312
u03B1-diglucosyldiacylglycerol biosynthesis24
luteolin glycosides biosynthesis19
galactolipid biosynthesis I64
apigenin glycosides biosynthesis114
proanthocyanidins biosynthesis from flavanols511
baicalein metabolism314
galactolipid biosynthesis II35
wogonin metabolism39
eriodictyol C-glucosylation310
isovitexin glycosides biosynthesis025
bacillithiol biosynthesis410
maysin biosynthesis07
blasticidin S biosynthesis925
superpathway of neomycin biosynthesis1037
glucosinolate biosynthesis from tetrahomomethionine1027
superpathway of pyrimidine nucleobases salvage1126
glucosinolate biosynthesis from phenylalanine629
glucosinolate biosynthesis from pentahomomethionine1127
glucosinolate biosynthesis from dihomomethionine1238
paromomycin biosynthesis620
glucosinolate biosynthesis from tryptophan532
glucosinolate biosynthesis from hexahomomethionine1227
glucosinolate biosynthesis from trihomomethionine1129
glucosinolate biosynthesis from tyrosine024
glucosinolate biosynthesis from homomethionine935
kanamycin biosynthesis1042
superpathway of rifamycin B biosynthesis1354
mycothiol biosynthesis520
validamycin biosynthesis1034
gentamicin biosynthesis426
arginomycin biosynthesis722
neomycin biosynthesis420
D-galactose degradation I (Leloir pathway)1046
kanosamine biosynthesis I211
u03B2-D-galactosaminyl-(1u21923)-N-acetyl-u03B1-D-galactosamine biosynthesis110
Escherichia coli serotype O86 O-antigen biosynthesis516
cardenolide glucosides biosynthesis011
crocetin esters biosynthesis39
crocetin biosynthesis113
lauryl-hydroxychlorobactene glucoside biosynthesis310
CMP-N-acetyl-7-O-acetylneuraminate biosynthesis117
zeaxanthin-u03B2-D-diglucoside biosynthesis16
CMP-pseudaminate biosynthesis523
CMP-diacetamido-8-epilegionaminic acid biosynthesis719
xylan biosynthesis05
superpathway of CMP-sialic acids biosynthesis1460
vitamin K degradation08
sucrose degradation II (sucrose synthase)1320
jasmonoyl-L-isoleucine inactivation516
tuberonate glucoside biosynthesis010
cytokinins 7-N-glucoside biosynthesis219
cytokinins 9-N-glucoside biosynthesis217
cytokinin-O-glucosides biosynthesis615
superpathway of glycosphingolipids biosynthesis2316
afrormosin conjugates interconversion09
genistin gentiobioside biosynthesis16
UDP-u03B1-D-xylose biosynthesis821
salicylate glucosides biosynthesis I16
sucrose biosynthesis I (from photosynthesis)1326
UDP-u03B1-D-galactose biosynthesis418
superpathway of pyrimidine ribonucleotides de novo biosynthesis2345
superpathway of hydrolyzable tannin biosynthesis030
superpathway of flavones and derivatives biosynthesis1064
superpathway of linamarin and lotaustralin biosynthesis023
UDP-D-apiose biosynthesis (from UDP-D-glucuronate)116
UDP-u03B1-D-galacturonate biosynthesis I (from UDP-D-glucuronate)211
L-ascorbate biosynthesis IV522
superpathway of formononetin derivative biosynthesis234
UDP-u03B2-L-rhamnose biosynthesis412
superpathway of UDP-glucose-derived O-antigen building blocks biosynthesis1139
betacyanin biosynthesis124
superpathway of betalain biosynthesis252
amaranthin biosynthesis013
hispidol and hispidol 4'-O-u03B2-D-glucoside biosynthesis018
saponin biosynthesis III012
des-methyl avenacin A-1 biosynthesis37
salvianin biosynthesis122
saponin biosynthesis IV116
pelargonidin conjugates biosynthesis225
ginsenosides biosynthesis1032
anthocyanidin acylglucoside and acylsambubioside biosynthesis327
soybean saponin I biosynthesis516
superpathway of anthocyanin biosynthesis (from cyanidin and cyanidin 3-O-glucoside)424
violdelphin biosynthesis517
superpathway of avenacin A biosynthesis522
gentiodelphin biosynthesis116
acylated cyanidin galactoside biosynthesis116
avenacin A-1 biosynthesis214
shisonin biosynthesis120
saponin biosynthesis II017
lacto-series glycosphingolipids biosynthesis89
indole-3-acetate inactivation III012
luteolinidin 5-O-glucoside biosynthesis417
superpathway of indole-3-acetate conjugate biosynthesis533
superpathway of anthocyanin biosynthesis (from delphinidin 3-O-glucoside)121
sphingolipid biosynthesis (plants)1226
anthocyanidin modification (Arabidopsis)820
anthocyanidin sophoroside metabolism08
anthocyanin biosynthesis (pelargonidin 3-O-glucoside)213
rose anthocyanin biosynthesis I (via cyanidin 5-O-u03B2-D-glucoside)06
anthocyanin biosynthesis29
apigeninidin 5-O-glucoside biosynthesis317
anthocyanidin sambubioside biosynthesis117
gala-series glycosphingolipids biosynthesis37
superpathway of anthocyanin biosynthesis (from pelargonidin 3-O-glucoside)233
superpathway of anaerobic sucrose degradation2661
flavonoid di-C-glucosylation029
ganglio-series glycosphingolipids biosynthesis910
neolacto-series glycosphingolipids biosynthesis108
globo-series glycosphingolipids biosynthesis911
curcumin glucoside biosynthesis113
superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis4662
benzoyl-u03B2-D-glucopyranose biosynthesis24
trehalose biosynthesis I719
trehalose biosynthesis VII15
biosynthesis of Lewis epitopes (H. pylori)57
6'-deoxychalcone metabolism016
chalcone 2'-O-glucoside biosynthesis05
mucin core 3 and core 4 O-glycosylation26
flavonol acylglucoside biosynthesis III - quercetin derivatives014
kaempferide triglycoside biosynthesis118
rutin biosynthesis113
protein O-mannosylation III (mammals, core M3)811
eupatolitin 3-O-glucoside biosynthesis031
quercetin glycoside biosynthesis (Arabidopsis)417
superpathway of polymethylated quercetin/quercetagetin glucoside biosynthesis (Chrysosplenium)246
ajmaline and sarpagine biosynthesis238
complex N-linked glycan biosynthesis (vertebrates)1417
quercetin gentiotetraside biosynthesis319
complex N-linked glycan biosynthesis (plants)816
flavonol acylglucoside biosynthesis I - kaempferol derivatives015
dolichyl glucosyl phosphate biosynthesis412
de novo biosynthesis of pyrimidine ribonucleotides1024
trehalose biosynthesis414
protein N-glycosylation (eukaryotic) initial steps2930
protein N-glycosylation (eukaryotic, high mannose)1522
UDP-D-galacturonate biosynthesis I (from UDP-D-glucuronate)15
pyrimidine ribonucleotides interconversion1214
UDP-D-xylose biosynthesis711
tetrahydrofolate biosynthesis II2333
D-galactose degradation III419
abscisic acid glucose ester metabolism127
scopolin biosynthesis05
glycophosphatidylinositol (GPI) anchor biosynthesis07
lipophosphoglycan (LPG) biosynthesis012
sucrose biosynthesis014
pyrimidine nucleotide metabolism (phosphotransfer and nucleotide modification)012
pyrimidine ribonucleotides de novo biosynthesis022
glycoinositolphospholipid (GIPL) biosynthesis011
sucrose degradation to ethanol and lactate (anaerobic)028
galactose degradation III017
purine and pyrimidine metabolism032
superpathway of histidine, purine, and pyrimidine biosynthesis064
peptidoglycan and lipid A precursor biosynthesis034
tetrahydrofolate biosynthesis I028
Lipid A-core biosynthesis018
mycolyl-arabinogalactan-peptidoglycan complex biosynthesis2131
superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli)519
nicotine degradation III4326
L-ascorbate biosynthesis VI519
nicotine degradation II4927
salvage pathways of purine and pyrimidine nucleotides030
teichoic acid (poly-glycerol) biosynthesis015
sulfolipid biosynthesis17
Chrysolaminaran biosynthesis010
glycolipid biosynthesis03
glycogen biosynthesis03
superpathway of histidine, purine and pyrimidine biosynthesis031
Relationship between glutathione and NADPH036
Sucrose biosynthesis06
Glucose-1-phosphate metabolism010
Trehalose anabolism07
Poly(glycerol phosphate) wall teichoic acid biosynthesis012
Sucrose metabolism1413
Biochemical pathways: part I0466
Valproic acid pathway022
Pyrimidine metabolism038
Pyrimidine metabolism and related diseases1844
Glycosylation and related congenital defects2426
Glucuronidation014
Mannosyl-chito-dolichol biosynthesis112
Stachyose biosynthesis27
Cellulose biosynthesis03
Sucrose biosynthesis012
Peptidoglycan biosynthesis I121
Galactose degradation II015
Trehalose biosynthesis18
Xyloglucan biosynthesis18
Xylogalacturonan biosynthesis02
Tetrahydrofolate biosynthesis II128
IAA conjugation I010
Cytokinins conjugates biosynthesis08
Cytokinins 9-N-glucoside biosynthesis014
Cytokinins-O-glucoside biosynthesis06
Abscisic acid homeostasis216
Anthocyanin biosynthesis (delphinidin 3-O-glucoside)010
Anthocyanin biosynthesis (pelargonidin 3-O-glucoside, cyanidin 3-O-glucoside)013
Coumarin biosynthesis (via 2-coumarate)114
Crocetin biosynthesis19
Gentiodelphin biosynthesis16
Lipid-A-precursor biosynthesis313

Protein Targets (29)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Cytotoxin LPaeniclostridium sordelliiIC50 (µMol)30.000030.000030.000030.0000AID977608
Chain A, Seminal ribonucleaseBos taurus (cattle)Ki1,046.40001,046.40001,046.40001,046.4000AID977610
Chain B, Seminal ribonucleaseBos taurus (cattle)Ki1,046.40001,046.40001,046.40001,046.4000AID977610
Chain A, Seminal ribonucleaseBos taurus (cattle)Ki1,046.40001,046.40001,046.40001,046.4000AID977610
Chain B, Seminal ribonucleaseBos taurus (cattle)Ki1,046.40001,046.40001,046.40001,046.4000AID977610
Chain A, Seminal ribonucleaseBos taurus (cattle)Ki1,046.40001,046.40001,046.40001,046.4000AID977610
Chain B, Seminal ribonucleaseBos taurus (cattle)Ki1,046.40001,046.40001,046.40001,046.4000AID977610
Chain A, Seminal ribonucleaseBos taurus (cattle)Ki1,046.40001,046.40001,046.40001,046.4000AID977610
Chain B, Seminal ribonucleaseBos taurus (cattle)Ki1,046.40001,046.40001,046.40001,046.4000AID977610
Chain A, Seminal ribonucleaseBos taurus (cattle)Ki1,046.40001,046.40001,046.40001,046.4000AID977610
Chain B, Seminal ribonucleaseBos taurus (cattle)Ki1,046.40001,046.40001,046.40001,046.4000AID977610
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)IC50 (µMol)1.80001.80001.80001.8000AID568345
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, GlucosyltransferaseLegionella pneumophilaKd0.10000.10000.10000.1000AID977611
Chain A, Udp-n-acetylglucosamine--peptide N-acetylglucosaminyl Transferase 110 Kda SubunitHomo sapiens (human)Kd0.54000.54000.54000.5400AID977611
Chain A, Udp-n-acetylglucosamine--peptide N-acetylglucosaminyltrans Ferase 110 Kda SubunitHomo sapiens (human)Kd0.54000.54000.54000.5400AID977611
Chain A, Toxin AClostridioides difficileKd11.400011.400011.400011.4000AID977611
P2Y purinoceptor 2Homo sapiens (human)EC50 (µMol)42.16670.00560.682810.0000AID150321; AID593124; AID89269
P2Y purinoceptor 1Homo sapiens (human)EC50 (µMol)100.00000.00130.42027.2000AID150331
P2Y purinoceptor 4Homo sapiens (human)EC50 (µMol)14.00000.02301.362310.0000AID593125
P2Y purinoceptor 6Homo sapiens (human)EC50 (µMol)0.14900.01302.393020.0000AID150635; AID150636; AID256769; AID271163; AID272722; AID404830; AID444562; AID460812; AID484784; AID593126; AID682411; AID682412; AID682415; AID89273
P2Y purinoceptor 14Homo sapiens (human)EC50 (µMol)53.44000.16000.37650.6700AID1232374; AID444563; AID484782
P2Y purinoceptor 6Rattus norvegicus (Norway rat)EC50 (µMol)0.20000.20000.20000.2000AID373704; AID647896
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (97)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IIUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
mitophagyUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
positive regulation of transcription from RNA polymerase II promoter by glucoseUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
regulation of glycolytic processUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
regulation of gluconeogenesisUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
chromatin organizationUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
regulation of transcription by RNA polymerase IIUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
protein O-linked glycosylationUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
apoptotic processUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
signal transductionUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
response to nutrientUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
protein processingUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
hemopoiesisUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
negative regulation of cell migrationUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
negative regulation of protein ubiquitinationUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
negative regulation of proteasomal ubiquitin-dependent protein catabolic processUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
response to insulinUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
circadian regulation of gene expressionUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
regulation of Rac protein signal transductionUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
positive regulation of translationUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
positive regulation of proteolysisUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
positive regulation of DNA-templated transcriptionUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
regulation of insulin receptor signaling pathwayUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
positive regulation of lipid biosynthetic processUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
regulation of synapse assemblyUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
regulation of necroptotic processUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
cellular response to glucose stimulusUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
regulation of neurotransmitter receptor localization to postsynaptic specialization membraneUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
positive regulation of cold-induced thermogenesisUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
negative regulation of stem cell population maintenanceUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
positive regulation of stem cell population maintenanceUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
positive regulation of TORC1 signalingUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
defense response to virusSeminal ribonucleaseBos taurus (cattle)
DNA synthesis involved in DNA repairRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
pyrimidine nucleobase metabolic processRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
mitochondrial DNA replicationRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
DNA repairRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
male gonad developmentRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
ribonucleoside diphosphate metabolic processRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
deoxyribonucleotide biosynthetic processRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
2'-deoxyribonucleotide biosynthetic processRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
response to ionizing radiationRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
cell proliferation in forebrainRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
protein heterotetramerizationRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
retina development in camera-type eyeRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
positive regulation of G0 to G1 transitionRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
blastocyst developmentRibonucleoside-diphosphate reductase subunit M2Homo sapiens (human)
ribonucleoside diphosphate metabolic processRibonucleoside-diphosphate reductase subunit M2Homo sapiens (human)
deoxyribonucleotide biosynthetic processRibonucleoside-diphosphate reductase subunit M2Homo sapiens (human)
2'-deoxyribonucleotide biosynthetic processRibonucleoside-diphosphate reductase subunit M2Homo sapiens (human)
protein heterotetramerizationRibonucleoside-diphosphate reductase subunit M2Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleRibonucleoside-diphosphate reductase subunit M2Homo sapiens (human)
intracellular monoatomic ion homeostasisP2Y purinoceptor 2Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayP2Y purinoceptor 2Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor signaling pathwayP2Y purinoceptor 2Homo sapiens (human)
positive regulation of mucus secretionP2Y purinoceptor 2Homo sapiens (human)
cellular response to ATPP2Y purinoceptor 2Homo sapiens (human)
blood vessel diameter maintenanceP2Y purinoceptor 2Homo sapiens (human)
G protein-coupled receptor signaling pathwayP2Y purinoceptor 2Homo sapiens (human)
positive regulation of protein phosphorylationP2Y purinoceptor 1Homo sapiens (human)
G protein-coupled adenosine receptor signaling pathwayP2Y purinoceptor 1Homo sapiens (human)
monoatomic ion transportP2Y purinoceptor 1Homo sapiens (human)
cell surface receptor signaling pathwayP2Y purinoceptor 1Homo sapiens (human)
G protein-coupled receptor signaling pathwayP2Y purinoceptor 1Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayP2Y purinoceptor 1Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayP2Y purinoceptor 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationP2Y purinoceptor 1Homo sapiens (human)
glial cell migrationP2Y purinoceptor 1Homo sapiens (human)
regulation of cell shapeP2Y purinoceptor 1Homo sapiens (human)
response to mechanical stimulusP2Y purinoceptor 1Homo sapiens (human)
negative regulation of norepinephrine secretionP2Y purinoceptor 1Homo sapiens (human)
signal transduction involved in regulation of gene expressionP2Y purinoceptor 1Homo sapiens (human)
platelet activationP2Y purinoceptor 1Homo sapiens (human)
positive regulation of inositol trisphosphate biosynthetic processP2Y purinoceptor 1Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor signaling pathwayP2Y purinoceptor 1Homo sapiens (human)
eating behaviorP2Y purinoceptor 1Homo sapiens (human)
positive regulation of monoatomic ion transportP2Y purinoceptor 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIP2Y purinoceptor 1Homo sapiens (human)
positive regulation of hormone secretionP2Y purinoceptor 1Homo sapiens (human)
establishment of localization in cellP2Y purinoceptor 1Homo sapiens (human)
positive regulation of penile erectionP2Y purinoceptor 1Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeP2Y purinoceptor 1Homo sapiens (human)
response to growth factorP2Y purinoceptor 1Homo sapiens (human)
cellular response to ATPP2Y purinoceptor 1Homo sapiens (human)
cellular response to purine-containing compoundP2Y purinoceptor 1Homo sapiens (human)
protein localization to plasma membraneP2Y purinoceptor 1Homo sapiens (human)
relaxation of muscleP2Y purinoceptor 1Homo sapiens (human)
blood vessel diameter maintenanceP2Y purinoceptor 1Homo sapiens (human)
regulation of presynaptic cytosolic calcium ion concentrationP2Y purinoceptor 1Homo sapiens (human)
regulation of synaptic vesicle exocytosisP2Y purinoceptor 1Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayP2Y purinoceptor 4Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationP2Y purinoceptor 4Homo sapiens (human)
transepithelial chloride transportP2Y purinoceptor 4Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor signaling pathwayP2Y purinoceptor 4Homo sapiens (human)
cellular response to ATPP2Y purinoceptor 4Homo sapiens (human)
cellular response to prostaglandin E stimulusP2Y purinoceptor 4Homo sapiens (human)
regulation of presynaptic cytosolic calcium ion concentrationP2Y purinoceptor 4Homo sapiens (human)
regulation of synaptic vesicle exocytosisP2Y purinoceptor 4Homo sapiens (human)
G protein-coupled receptor signaling pathwayP2Y purinoceptor 4Homo sapiens (human)
phagocytosisP2Y purinoceptor 6Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayP2Y purinoceptor 6Homo sapiens (human)
activation of phospholipase C activityP2Y purinoceptor 6Homo sapiens (human)
positive regulation of smooth muscle cell migrationP2Y purinoceptor 6Homo sapiens (human)
transepithelial chloride transportP2Y purinoceptor 6Homo sapiens (human)
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activityP2Y purinoceptor 6Homo sapiens (human)
positive regulation of inositol trisphosphate biosynthetic processP2Y purinoceptor 6Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor signaling pathwayP2Y purinoceptor 6Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeP2Y purinoceptor 6Homo sapiens (human)
cellular response to prostaglandin E stimulusP2Y purinoceptor 6Homo sapiens (human)
cellular response to purine-containing compoundP2Y purinoceptor 6Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferationP2Y purinoceptor 6Homo sapiens (human)
cellular response to pyrimidine ribonucleotideP2Y purinoceptor 6Homo sapiens (human)
G protein-coupled receptor signaling pathwayP2Y purinoceptor 6Homo sapiens (human)
G protein-coupled receptor signaling pathwayP2Y purinoceptor 14Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor signaling pathwayP2Y purinoceptor 14Homo sapiens (human)
DNA synthesis involved in DNA repairRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
kidney developmentRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
renal system processRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
mitochondrial DNA replicationRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
DNA repairRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
response to oxidative stressRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
ribonucleoside diphosphate metabolic processRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
deoxyribonucleoside triphosphate metabolic processRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
2'-deoxyribonucleotide biosynthetic processRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
response to amineRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
positive regulation of G0 to G1 transitionRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediatorRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
deoxyribonucleotide biosynthetic processRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (28)

Processvia Protein(s)Taxonomy
protein bindingUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
phosphatidylinositol-3,4,5-trisphosphate bindingUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
acetylglucosaminyltransferase activityUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
chromatin DNA bindingUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
protein O-acetylglucosaminyltransferase activityUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
nucleic acid bindingSeminal ribonucleaseBos taurus (cattle)
ribonuclease A activitySeminal ribonucleaseBos taurus (cattle)
RNA nuclease activitySeminal ribonucleaseBos taurus (cattle)
lyase activitySeminal ribonucleaseBos taurus (cattle)
identical protein bindingSeminal ribonucleaseBos taurus (cattle)
ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptorRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
protein bindingRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
identical protein bindingRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
ribonucleoside-diphosphate reductase activityRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
disordered domain specific bindingRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
ATP bindingRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptorRibonucleoside-diphosphate reductase subunit M2Homo sapiens (human)
protein bindingRibonucleoside-diphosphate reductase subunit M2Homo sapiens (human)
ferric iron bindingRibonucleoside-diphosphate reductase subunit M2Homo sapiens (human)
protein homodimerization activityRibonucleoside-diphosphate reductase subunit M2Homo sapiens (human)
protein bindingP2Y purinoceptor 2Homo sapiens (human)
signaling receptor activityP2Y purinoceptor 2Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor activityP2Y purinoceptor 2Homo sapiens (human)
A1 adenosine receptor bindingP2Y purinoceptor 2Homo sapiens (human)
G protein-coupled UTP receptor activityP2Y purinoceptor 2Homo sapiens (human)
G protein-coupled ADP receptor activityP2Y purinoceptor 1Homo sapiens (human)
protein bindingP2Y purinoceptor 1Homo sapiens (human)
ATP bindingP2Y purinoceptor 1Homo sapiens (human)
signaling receptor activityP2Y purinoceptor 1Homo sapiens (human)
ADP bindingP2Y purinoceptor 1Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor activityP2Y purinoceptor 1Homo sapiens (human)
G protein-coupled ATP receptor activityP2Y purinoceptor 1Homo sapiens (human)
protein heterodimerization activityP2Y purinoceptor 1Homo sapiens (human)
scaffold protein bindingP2Y purinoceptor 1Homo sapiens (human)
A1 adenosine receptor bindingP2Y purinoceptor 1Homo sapiens (human)
protein bindingP2Y purinoceptor 4Homo sapiens (human)
ATP bindingP2Y purinoceptor 4Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor activityP2Y purinoceptor 4Homo sapiens (human)
G protein-coupled UTP receptor activityP2Y purinoceptor 4Homo sapiens (human)
nucleic acid bindingRibonuclease pancreaticBos taurus (cattle)
ribonuclease A activityRibonuclease pancreaticBos taurus (cattle)
protein bindingRibonuclease pancreaticBos taurus (cattle)
lyase activityRibonuclease pancreaticBos taurus (cattle)
G protein-coupled ADP receptor activityP2Y purinoceptor 6Homo sapiens (human)
G protein-coupled receptor activityP2Y purinoceptor 6Homo sapiens (human)
protein bindingP2Y purinoceptor 6Homo sapiens (human)
G protein-coupled UDP receptor activityP2Y purinoceptor 6Homo sapiens (human)
G protein-coupled UTP receptor activityP2Y purinoceptor 6Homo sapiens (human)
G protein-coupled UDP receptor activityP2Y purinoceptor 14Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor activityP2Y purinoceptor 14Homo sapiens (human)
protein bindingRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
identical protein bindingRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
metal ion bindingRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptorRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (27)

Processvia Protein(s)Taxonomy
nucleusUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
nucleoplasmUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
cytosolUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
plasma membraneUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
mitochondrial membraneUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
cell projectionUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
NSL complexUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
Sin3-type complexUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
glutamatergic synapseUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
histone acetyltransferase complexUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
protein N-acetylglucosaminyltransferase complexUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
protein-containing complexUDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitHomo sapiens (human)
extracellular regionSeminal ribonucleaseBos taurus (cattle)
nuclear envelopeRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
mitochondrionRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
cytosolRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
ribonucleoside-diphosphate reductase complexRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
cell projectionRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
neuronal cell bodyRibonucleoside-diphosphate reductase large subunitHomo sapiens (human)
nucleusRibonucleoside-diphosphate reductase subunit M2Homo sapiens (human)
cytosolRibonucleoside-diphosphate reductase subunit M2Homo sapiens (human)
ribonucleoside-diphosphate reductase complexRibonucleoside-diphosphate reductase subunit M2Homo sapiens (human)
cytosolRibonucleoside-diphosphate reductase subunit M2Homo sapiens (human)
plasma membraneP2Y purinoceptor 2Homo sapiens (human)
plasma membraneP2Y purinoceptor 2Homo sapiens (human)
plasma membraneP2Y purinoceptor 1Homo sapiens (human)
ciliumP2Y purinoceptor 1Homo sapiens (human)
cell surfaceP2Y purinoceptor 1Homo sapiens (human)
postsynaptic densityP2Y purinoceptor 1Homo sapiens (human)
basolateral plasma membraneP2Y purinoceptor 1Homo sapiens (human)
apical plasma membraneP2Y purinoceptor 1Homo sapiens (human)
dendriteP2Y purinoceptor 1Homo sapiens (human)
cell bodyP2Y purinoceptor 1Homo sapiens (human)
postsynaptic membraneP2Y purinoceptor 1Homo sapiens (human)
presynaptic active zone membraneP2Y purinoceptor 1Homo sapiens (human)
glutamatergic synapseP2Y purinoceptor 1Homo sapiens (human)
plasma membraneP2Y purinoceptor 1Homo sapiens (human)
plasma membraneP2Y purinoceptor 4Homo sapiens (human)
basolateral plasma membraneP2Y purinoceptor 4Homo sapiens (human)
apical plasma membraneP2Y purinoceptor 4Homo sapiens (human)
presynaptic active zone membraneP2Y purinoceptor 4Homo sapiens (human)
glutamatergic synapseP2Y purinoceptor 4Homo sapiens (human)
plasma membraneP2Y purinoceptor 4Homo sapiens (human)
extracellular regionRibonuclease pancreaticBos taurus (cattle)
plasma membraneP2Y purinoceptor 6Homo sapiens (human)
basolateral plasma membraneP2Y purinoceptor 6Homo sapiens (human)
apical plasma membraneP2Y purinoceptor 6Homo sapiens (human)
plasma membraneP2Y purinoceptor 6Homo sapiens (human)
plasma membraneP2Y purinoceptor 14Homo sapiens (human)
membraneP2Y purinoceptor 14Homo sapiens (human)
nucleoplasmRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
mitochondrionRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
cytosolRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
ribonucleoside-diphosphate reductase complexRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
cytosolRibonucleoside-diphosphate reductase subunit M2 BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (93)

Assay IDTitleYearJournalArticle
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2010The Biochemical journal, Feb-24, Volume: 426, Issue:3
Molecular mechanism of elongation factor 1A inhibition by a Legionella pneumophila glycosyltransferase.
AID977608Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB2008FEBS letters, Jun-25, Volume: 582, Issue:15
Inhibition of the glucosyltransferase activity of clostridial Rho/Ras-glucosylating toxins by castanospermine.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Mapping the ribonucleolytic active site of bovine seminal ribonuclease. The binding of pyrimidinyl phosphonucleotide inhibitors.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2012The FEBS journal, Sep, Volume: 279, Issue:17
The structure of Clostridium difficile toxin A glucosyltransferase domain bound to Mn2+ and UDP provides insights into glucosyltransferase activity and product release.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2012Nature chemical biology, Dec, Volume: 8, Issue:12
O-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysis.
AID469230Inhibition of bovine seminal ribonuclease assessed as enzyme activity by spectrophotometric method at pH 62009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Mapping the ribonucleolytic active site of bovine seminal ribonuclease. The binding of pyrimidinyl phosphonucleotide inhibitors.
AID330932Reversal of drug-induced phagocytosis in Wistar rat microglia at 100 uM in presence of MRS25782007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID469231Inhibition of bovine pancreatic ribonuclease A assessed as enzyme activity by spectrophotometric method pH 62009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Mapping the ribonucleolytic active site of bovine seminal ribonuclease. The binding of pyrimidinyl phosphonucleotide inhibitors.
AID1862163Inhibition of Mycobacterium tuberculosis UGM expressed in Escherichia coli BL21(DE3) at 500 uM by Fluorescence polarization assay relative to control2022Bioorganic & medicinal chemistry, 09-01, Volume: 69Synthesis and evaluation of inhibitors of Mycobacterium tuberculosis UGM using bioisosteric replacement.
AID444563Agonist activity at human P2Y14 receptor expressed in HEK293 cells coexpressing phospholipase C-activating Gi protein cells assessed as inhibition of forskolin induced [3H]cAMP production2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Human P2Y(14) receptor agonists: truncation of the hexose moiety of uridine-5'-diphosphoglucose and its replacement with alkyl and aryl groups.
AID330917Activity at P2Y6 receptor in Wistar rat microglia assessed as inhibition of intracellular calcium concentration at 100 uM after 600 secs by ratiometric fura-2 fluorescence method in presence of xestospongin C2007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID718079Competitive inhibition of bovine pancreatic RNase A type 12-A by Dixon plot analysis2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Triazole pyrimidine nucleosides as inhibitors of Ribonuclease A. Synthesis, biochemical, and structural evaluation.
AID330915Activity at P2Y6 receptor in Wistar rat microglia assessed as inhibition of intracellular calcium concentration at 100 uM after 300 secs by ratiometric fura-2 fluorescence method in presence of U731222007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID150635Measure of Agonist Potency at human P2Y purinoceptor 6 (hP2Y6) stably expressed in 131N1 astrocytoma cell2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
AID330926Effect on formation of phagosome-like vacuoles in Wistar rat microglia at 100 uM after 5 mins2007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID330914Agonist activity at P2Y6 receptor in Wistar rat microglia assessed as increase in intracellular calcium concentration by ratiometric fura-2 fluorescence method2007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID682425Agonist activity at P2Y6 receptor in New Zealand White rabbit osteoclasts assessed as intracellular calcium mobilization by fura2-based microfluorimetric technique2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.
AID648185Agonist activity at human P2Y6 receptor expressed in human 1321N1 cells assessed as stimulation of PLC-induced [3H]inositol phosphate production at 100 uM after 30 mins by scintillation counting2012Bioorganic & medicinal chemistry, Apr-01, Volume: 20, Issue:7
Synthesis and P2Y₂ receptor agonist activities of uridine 5'-phosphonate analogues.
AID89272Agonist activity evaluated as change in the level of cytosolic calcium in 1321N astrocytoma cells infected with a retrovirus encoding the human P2Y4 receptor at 100 uM; IA is inactive2001Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2
Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.
AID1862162Inhibition of Klebsiella pneumoniae UGM expressed in Escherichia coli BL21(DE3) at 500 uM by Fluorescence polarization assay relative to control2022Bioorganic & medicinal chemistry, 09-01, Volume: 69Synthesis and evaluation of inhibitors of Mycobacterium tuberculosis UGM using bioisosteric replacement.
AID1862164Inhibition of Klebsiella pneumoniae UGM expressed in Escherichia coli BL21(DE3) assessed as dissociation constant by fluorescence polarization assay2022Bioorganic & medicinal chemistry, 09-01, Volume: 69Synthesis and evaluation of inhibitors of Mycobacterium tuberculosis UGM using bioisosteric replacement.
AID1862166Inhibition of Mycobacterium tuberculosis UGM expressed in Escherichia coli BL21(DE3) assessed as formation of UDP-galactopyranose at 500 uM preincubated for 5 min followed by substrate addition and measured after 1 to 3 mins using UDP-galactofuranose as s2022Bioorganic & medicinal chemistry, 09-01, Volume: 69Synthesis and evaluation of inhibitors of Mycobacterium tuberculosis UGM using bioisosteric replacement.
AID330920Activity at P2Y6 receptor in Wistar rat microglia assessed as inhibition of intracellular calcium concentration at 100 uM by ratiometric fura-2 fluorescence method in presence of MRS25782007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID330923Effect on P2Y6 receptor-mediated cell motility in Wistar rat microglia at 100 uM by chemotaxis assay2007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID330931Reversal of drug-induced of phagocytosis in Wistar rat microglia at 100 uM in presence of suramin2007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID677172Binding affinity to Neisseria meningitidis alpha-1,4-GalT after 15 mins by competitive binding assay2012Journal of medicinal chemistry, Mar-08, Volume: 55, Issue:5
Inhibition of galactosyltransferases by a novel class of donor analogues.
AID484784Agonist activity at human recombinant P2Y6 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate production by scintillation proximity assay2010Journal of medicinal chemistry, Jun-10, Volume: 53, Issue:11
Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.
AID460812Agonist activity at human P2Y6 receptor expressed in human 1321N1 cells assessed as calcium elevation by fura2/AM assay2010Journal of medicinal chemistry, Feb-25, Volume: 53, Issue:4
5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.
AID197980Compound was evaluated for time-dependent inactivation of Ribonucleotide diphosphate reductase (RDPR) in Escherichia coli1991Journal of medicinal chemistry, Jun, Volume: 34, Issue:6
2'-Deoxy-2'-methylenecytidine and 2'-deoxy-2',2'-difluorocytidine 5'-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase.
AID330930Reversal of drug-induced of phagocytosis in Wistar rat microglia at 100 uM in presence of reactive blue 22007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID484782Agonist activity at human recombinant P2Y14 receptor expressed in HEK293 cells assessed as [3H]inositol phosphate production by scintillation proximity assay2010Journal of medicinal chemistry, Jun-10, Volume: 53, Issue:11
Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.
AID431263Activity of cloned NDPK in human HuH7 cells assessed as formation of uridine triphosphate by spectrophotometry2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
The mechanism of action of beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine involves a second metabolic pathway leading to beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.
AID1137665Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO-K1 cell membranes up to 1 mM after 60 mins by liquid scintillation counting2014ACS medicinal chemistry letters, Apr-10, Volume: 5, Issue:4
Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17.
AID444562Agonist activity at human P2Y6 receptor expressed in human 1321N1 cells coexpressing phospholipase C-activating Gq protein assessed as [3H]inositol phosphate production2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Human P2Y(14) receptor agonists: truncation of the hexose moiety of uridine-5'-diphosphoglucose and its replacement with alkyl and aryl groups.
AID330924Effect on formation of F-actin aggregation in Wistar rat microglia at 100 uM after 5 mins2007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID682422Drug metabolism in human serum assessed as nucleoside 5'-monophosphate formation incubated up to 24 hrs by HPLC analysis2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.
AID682419Half life in KCl/HCl buffer by 31P-NMR analysis at pH 1.42012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.
AID272719Agonist activity at human P2Y4 receptor expressed in 1321N1 cells assessed as IP accumulation by SPA2006Journal of medicinal chemistry, Nov-30, Volume: 49, Issue:24
Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.
AID593124Agonist activity at human recombinant P2Y2 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate intracellular accumulation by scintillation proximity assay2011Journal of medicinal chemistry, Apr-28, Volume: 54, Issue:8
Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors.
AID367517Inhibition of Escherichia coli UDP-galactopyranose mutase assessed as inhibition of conversion to UDP-galactopyranose2009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
Probing UDP-galactopyranose mutase binding pocket: a dramatic effect on substitution of the 6-position of UDP-galactofuranose.
AID682420Hydrolytic stability of the compound assessed as human NPP1-mediated hydrolysis measuring UMP formation after 2 hrs by HPLC analysis2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.
AID330934Agonist activity at CysLT1 receptor in Wistar rat microglia assessed as increase in intracellular calcium concentration at 30 uM by ratiometric fura-2 fluorescence method2007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID367518Binding affinity to Escherichia coli UDP-galactopyranose mutase2009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
Probing UDP-galactopyranose mutase binding pocket: a dramatic effect on substitution of the 6-position of UDP-galactofuranose.
AID150331Evaluated for agonist activity against phospholipase C coupled P2Y purinoceptor 1 (P2Y1) of human erythrocytes2002Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19
Purine and pyrimidine (P2) receptors as drug targets.
AID330935Activity at CysLT1 receptor expressed in CHO cells assessed as inhibition of in intracellular calcium concentration at 1 uM treated twice for 20 secs by ratiometric fura-2 fluorescence method in presence of MRS25782007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID1862165Inhibition of Mycobacterium tuberculosis UGM expressed in Escherichia coli BL21(DE3) assessed as dissociation constant by fluorescence polarization assay2022Bioorganic & medicinal chemistry, 09-01, Volume: 69Synthesis and evaluation of inhibitors of Mycobacterium tuberculosis UGM using bioisosteric replacement.
AID330916Activity at P2Y6 receptor in Wistar rat microglia assessed as inhibition of intracellular calcium concentration at 100 uM after 600 secs by ratiometric fura-2 fluorescence method in presence of thapsigargin2007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID404830Agonist activity at human P2Y6 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate accumulation by scintillation proximity assay2008Bioorganic & medicinal chemistry, Jun-15, Volume: 16, Issue:12
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.
AID150321Evaluated for agonist activity against phospholipase C coupled recombinant human P2Y purinoceptor 2 (P2Y2)2002Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19
Purine and pyrimidine (P2) receptors as drug targets.
AID89268Agonist activity evaluated as change in the level of cytosolic calcium in 1321N astrocytoma cells infected with a retrovirus encoding the human P2Y1 receptor at 100 uM; IA is inactive2001Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2
Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.
AID682421Hydrolytic stability of the compound assessed as human NPP3-mediated hydrolysis after 3 hrs by HPLC analysis2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.
AID682411Agonist activity at P2Y6 receptor expressed in human 1321N1 cells assessed as inositol phosphate accumulation2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.
AID330938Reversal of drug-induced phagocytosis in Wistar rat microglia at 100 uM in presence of thapsigargin2007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID330937Reversal of drug-induced phagocytosis in Wistar rat microglia at 100 uM in presence of U731222007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID272716Agonist activity at human P2Y2 receptor expressed in 1321N1 cells assessed as IP accumulation by SPA2006Journal of medicinal chemistry, Nov-30, Volume: 49, Issue:24
Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.
AID682412Agonist activity at human P2Y6 receptor2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.
AID593126Agonist activity at human recombinant P2Y6 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate intracellular accumulation by scintillation proximity assay2011Journal of medicinal chemistry, Apr-28, Volume: 54, Issue:8
Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors.
AID682424Half life in human serum by HPLC analysis2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.
AID330928Induction of phagocytosis in Wistar rat microglia assessed as uptake of microspheres after 20 mins by FACS2007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID256769Stimulation of phospholipase C in 1321N1 astrocytoma cells transfected with human P2Y6 receptor2005Journal of medicinal chemistry, Dec-29, Volume: 48, Issue:26
Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference.
AID1370004Drug metabolism at 2 mM at pH 1.7 at room temperature after 28 days by 31P NMR method2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P
AID647896Agonist activity at rat P2Y purinoceptor 6 expressed in human 1321N1 cells assessed as increase in intracellular calcium concentration by spectrofluorimetry2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.
AID373704Agonist activity at rat P2Y6 receptor expressed in human 1321N1 cells assessed as increase in intracellular calcium concentration by dual-excitation spectrofluorimetric analysis2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Identification of hydrolytically stable and selective P2Y(1) receptor agonists.
AID460576Agonist activity at human P2Y4 receptor expressed in human 1321N1 cells assessed as calcium elevation by fura2/AM assay2010Journal of medicinal chemistry, Feb-25, Volume: 53, Issue:4
5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.
AID330918Activity at P2Y6 receptor in Wistar rat microglia assessed as inhibition of intracellular calcium concentration at 100 uM by ratiometric fura-2 fluorescence method in presence of reactive blue 22007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID150636The compound was evaluated for agonist activity against phospholipase C coupled recombinant human P2Y purinoceptor 6 (P2Y6)2002Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19
Purine and pyrimidine (P2) receptors as drug targets.
AID568345Inhibition of human OGT2011Bioorganic & medicinal chemistry letters, Feb-15, Volume: 21, Issue:4
6''-Azido-6''-deoxy-UDP-N-acetylglucosamine as a glycosyltransferase substrate.
AID682415Agonist activity at human GFP-tagged P2Y6 receptor expressed in human 1321N1 cells assessed as intracellular calcium mobilization by fura2/AM-based fluorescence spectrophotometry2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.
AID330927Effect on formation of phagocytotic cup in Wistar rat microglia at 100 uM after 5 mins2007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID330919Activity at P2Y6 receptor in Wistar rat microglia assessed as inhibition of intracellular calcium concentration at 100 uM in presence of suramin by ratiometric fura-2 fluorescence method2007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID330921Effect on P2Y6 receptor-mediated cell motility in Wistar rat microglia assessed as formation of lamellipodia-like membrane ruffles at 100 uM after 5 mins2007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID89269Agonist activity evaluated as change in the level of cytosolic calcium in 1321N astrocytoma cells infected with a retrovirus encoding the human P2Y2 receptor2001Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2
Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.
AID330925Effect on formation of filopodia-like protrusions in Wistar rat microglia at 100 uM after 5 mins2007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID89273Agonist activity evaluated as change in the level of cytosolic calcium in 1321N astrocytoma cells infected with a retrovirus encoding the human P2Y6 receptor2001Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2
Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.
AID1605611Competitive inhibition of recombinant His-tagged yeast GYS2P expressed in Escherichia coli BL21(DE3) cells using UDPG as substrate in presence of G-6-P by 14C-glucose incorporation based Michaelis-Menton plot analysis2020Journal of medicinal chemistry, 04-09, Volume: 63, Issue:7
Discovery and Development of Small-Molecule Inhibitors of Glycogen Synthase.
AID271163Agonist activity at human recombinant P2Y6 receptor expressed in 1321N1 cells assessed as PLC-mediated [3H]IP production2006Journal of medicinal chemistry, Sep-07, Volume: 49, Issue:18
Structure-activity relationships of uridine 5'-diphosphate analogues at the human P2Y6 receptor.
AID431265Ratio of Kcat to Km for cloned NDPK in human HuH7 cells assessed as formation of uridine triphosphate by spectrophotometry2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
The mechanism of action of beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine involves a second metabolic pathway leading to beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.
AID197979Compound was evaluated for time-dependent inactivation of Ribonucleotide diphosphate reductase (RDPR) in Escherichia coli1991Journal of medicinal chemistry, Jun, Volume: 34, Issue:6
2'-Deoxy-2'-methylenecytidine and 2'-deoxy-2',2'-difluorocytidine 5'-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase.
AID1232374Agonist activity at recombinant human P2Y14 receptor expressed in African green monkey COS7 cells co-transfected with Galphaqi assessed as stimulation of phospholipase Cbeta2015Bioorganic & medicinal chemistry, Jul-15, Volume: 23, Issue:14
Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands.
AID460573Agonist activity at human P2Y2 receptor expressed in human 1321N1 cells assessed as calcium elevation by fura2/AM assay2010Journal of medicinal chemistry, Feb-25, Volume: 53, Issue:4
5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.
AID593125Agonist activity at human recombinant P2Y4 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate intracellular accumulation by scintillation proximity assay2011Journal of medicinal chemistry, Apr-28, Volume: 54, Issue:8
Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors.
AID272722Agonist activity at human P2Y6 receptor expressed in 1321N1 cells assessed as IP accumulation by SPA2006Journal of medicinal chemistry, Nov-30, Volume: 49, Issue:24
Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.
AID330939Reversal of drug-induced phagocytosis in Wistar rat microglia at 100 uM in presence of staurosporine2007Nature, Apr-26, Volume: 446, Issue:7139
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.
AID682423Drug metabolism in human serum assessed as nucleoside formation incubated up to 24 hrs by HPLC analysis2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.
AID1346426Human P2Y6 receptor (P2Y receptors)1996Biochemical and biophysical research communications, May-15, Volume: 222, Issue:2
Cloning, functional expression and tissue distribution of the human P2Y6 receptor.
AID1346625Mouse Kir6.1 (Inwardly rectifying potassium channels)1997The Journal of physiology, Mar-15, Volume: 499 ( Pt 3)Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel.
AID1346390Human P2Y14 receptor (P2Y receptors)2009Molecular pharmacology, Dec, Volume: 76, Issue:6
Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor.
AID1346914Human GPR17 (Class A Orphans)2006The EMBO journal, Oct-04, Volume: 25, Issue:19
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor.
AID1346914Human GPR17 (Class A Orphans)2010British journal of pharmacology, Mar, Volume: 159, Issue:5
Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants.
AID1346395Rat P2Y14 receptor (P2Y receptors)2008The Journal of pharmacology and experimental therapeutics, May, Volume: 325, Issue:2
UDP is a competitive antagonist at the human P2Y14 receptor.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,150)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990127 (11.04)18.7374
1990's162 (14.09)18.2507
2000's281 (24.43)29.6817
2010's290 (25.22)24.3611
2020's290 (25.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials4 (0.34%)5.53%
Reviews0 (0.00%)6.00%
Reviews61 (5.24%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies2 (0.17%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
Other1,097 (94.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research Highlights

Safety/Toxicity (2)

ArticleYear
Overexpression of UDP-sugar pyrophosphorylase leads to higher sensitivity towards galactose, providing new insights into the mechanisms of galactose toxicity in plants.
The Plant journal : for cell and molecular biology, Volume: 109, Issue: 6
2022
[Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy, Volume: 30, Issue: 3
2003
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pharmacokinetics (5)

ArticleYear
Development of UPLC-MS/MS Method to Study the Pharmacokinetic Interaction between Sorafenib and Dapagliflozin in Rats.
Molecules (Basel, Switzerland), Sep-21, Volume: 27, Issue: 19
2022
Evaluation of the Effect of Uridine Diphosphate-Glucuronosyltransferases (UGT) Inhibition by Valproic Acid on Vixotrigine Pharmacokinetics in Healthy Volunteers.
Clinical drug investigation, Volume: 42, Issue: 10
2022
Examining Physiologically Based Pharmacokinetic Model Assumptions for Cross-Tissue Similarity of Activity per Unit of Enzyme: The Case Example of Uridine 5'-Diphosphate Glucuronosyltransferase.
Drug metabolism and disposition: the biological fate of chemicals, Volume: 50, Issue: 8
2022
The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential.
Drug metabolism reviews, Volume: 42, Issue: 1
2010
Effect of aerosolized uridine-5'-triphosphate on airway clearance with cough in patients with primary ciliary dyskinesia.
American journal of respiratory and critical care medicine, Volume: 160, Issue: 1
1999
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (7)

ArticleYear
Dimethandrolone, a Potential Male Contraceptive Pill, is Primarily Metabolized by the Highly Polymorphic UDP-Glucuronosyltransferase 2B17 Enzyme in Human Intestine and Liver.
Drug metabolism and disposition: the biological fate of chemicals, Volume: 50, Issue: 12
2022
Development of screening methods for functional characterization of UGTs from Stevia rebaudiana.
Scientific reports, 09-15, Volume: 10, Issue: 1
2020
Comparative Analysis of High-Throughput Assays of Family-1 Plant Glycosyltransferases.
International journal of molecular sciences, Mar-23, Volume: 21, Issue: 6
2020
Wedelolactone metabolism in rats through regioselective glucuronidation catalyzed by uridine diphosphate-glucuronosyltransferases 1As (UGT1As).
Phytomedicine : international journal of phytotherapy and phytopharmacology, Apr-15, Volume: 23, Issue: 4
2016
Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions.
Molecular pharmaceutics, Apr-06, Volume: 12, Issue: 4
2015
Mapping the ribonucleolytic active site of bovine seminal ribonuclease. The binding of pyrimidinyl phosphonucleotide inhibitors.
European journal of medicinal chemistry, Volume: 44, Issue: 11
2009
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (5)

ArticleYear
Dimethandrolone, a Potential Male Contraceptive Pill, is Primarily Metabolized by the Highly Polymorphic UDP-Glucuronosyltransferase 2B17 Enzyme in Human Intestine and Liver.
Drug metabolism and disposition: the biological fate of chemicals, Volume: 50, Issue: 12
2022
Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review.
Pharmacology & therapeutics, Volume: 141, Issue: 1
2014
Hypotensive effect of UDP on intraocular pressure in rabbits.
European journal of pharmacology, Jan-28, Volume: 579, Issue: 1-3
2008
Dual effect of nucleotides on P2Y receptors.
IUBMB life, Volume: 50, Issue: 2
2000
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Interactions (5)

ArticleYear
Potential risk of drug-drug interactions of ponatinib via inhibition against human UDP-glucuronosyltransferases.
Toxicology in vitro : an international journal published in association with BIBRA, Volume: 92
2023
Drug-drug interaction potentials of tucatinib inhibition of human UDP-glucuronosyltransferases.
Chemico-biological interactions, Aug-25, Volume: 381
2023
Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance.
Pharmacology & therapeutics, Volume: 248
2023
The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential.
Drug metabolism reviews, Volume: 42, Issue: 1
2010
Drug interaction between mycophenolate mofetil and rifampin: possible induction of uridine diphosphate-glucuronosyltransferase.
Clinical pharmacology and therapeutics, Volume: 78, Issue: 1
2005
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]